Like most healthcare workers, I was thrilled when I was eligible to receive the COVID-19 vaccine. I’ve been involved in COVID-19 patient care since the very start of the pandemic in the US, and I had seen what this virus can do to people. We all felt incredibly helpless against this incredibly contagious bug. With… Read More »
The World Obesity Foundation released a new study Thursday that found a link between a country’s COVID-19 mortality and obesity prevalence in its population. The researchers found “high mortality rates only in countries where overweight prevalence exceeds around 50% of the adult population.” “Globally, at the end of 2020, COVID-19 mortality rates were more than ten… Read More »
Five years ago, in 2016, the W2O Group said that, “Relevance is reputation.” That year the firm began to study the relevance of, well, relevance for organizations especially operating in the health/care ecosystem. 2020 changed everything, the W2O team asserts, now issuing its latest look into the issue through the Relevance Quotient. Relevance is built… Read More »
For nearly a year, nursing homes and assisted living centers have been mostly closed to visitors. Now, it’s time for them to open back up and relieve residents of crushing isolation, according to a growing chorus of long-term care experts, caregivers, consumer groups and physicians. They’re calling for federal health authorities to relax visitation restrictions… Read More »
By Carolyn Comeau The safety and quality of life of Buncombe County’s babies and children are dependent on the adults around them. But sadly, over 4,000 children in Buncombe County alone experience neglect and physical or sexual abuse annually. – 1 in 5 children will experience abuse or neglect.– 50 percent of abuse victims are… Read More »
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »